DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Heron Therapeutics Q4 EPS $(0.65) Down From $(0.63) YoY, Sales $35.083M Up From $28.844M YoY

Heron Therapeutics (NASDAQ:HRTX) reported quarterly losses of $(0.65) per share. This is a 3.17 percent decrease over losses of $(0.63) per share from the same period last year. The company reported $35.083 million in

Benzinga · 03/02/2020 12:33

Heron Therapeutics (NASDAQ:HRTX) reported quarterly losses of $(0.65) per share. This is a 3.17 percent decrease over losses of $(0.63) per share from the same period last year. The company reported $35.083 million in sales this quarter. This is a 21.63 percent increase over sales of $28.844 million the same period last year.